Browse by intervention

Metformin: what it changed, and what it did not

One intervention, every measured benefit and result that did not improve. See who it moved for, where it stayed neutral or went the other way, and the next hypothesis Phoenix can validate.

How to read this

Observational research: real APOE4 carriers tracked over time, each compared with their own earlier self. Members chose their interventions, with no randomisation or placebo group. Everything else they changed is shown beside each result.

Read the full methods and limits

Key findings

Phoenix has measured Metformin against 4 exact outcomes for APOE4 carriers. Member #2351C3's Glucose moved from 114 to 88 mg/dL in 718 days. Member #15000A lowered fasting insulin from 12.6 to 6.5 uIU/mL in 162 days on metformin and tirzepatide, both undated. Member #2351C3's LDL cholesterol moved from 83 to 59 mg/dL in 881 days. Member #2351C3's Triglycerides moved from 101 to 62 mg/dL in 795 days.

Metformin evidence by outcome
OutcomeDirectionWhat we observed
GlucosePositive individual resultMember #2351C3's Glucose moved from 114 to 88 mg/dL in 718 days.
InsulinPositive individual resultMember #15000A lowered fasting insulin from 12.6 to 6.5 uIU/mL in 162 days on metformin and tirzepatide, both undated.
LDL cholesterolPositive individual resultMember #2351C3's LDL cholesterol moved from 83 to 59 mg/dL in 881 days.
TriglyceridesPositive individual resultMember #2351C3's Triglycerides moved from 101 to 62 mg/dL in 795 days.

Should I take metformin to protect my brain as an APOE4 carrier?

Metformin lowers blood sugar and HbA1c; that part is settled, and it probably lowers insulin resistance too. For the brain, it may lower dementia risk in people with diabetes, but that comes from observational studies, no prevention trial has reported yet, and a small human study and a mouse study hint that APOE4 carriers may benefit less. Whether it fits someone with high insulin or prediabetes is a question for your doctor, who may also check B12.

What the research says

Grade C

APOE4-specific evidence: limited

Metformin clearly improves blood sugar; people with diabetes who take it may have about a quarter less dementia in observational studies, but no trial has tested dementia prevention and the little APOE4 data suggests carriers gain less.

Key studies

  • Knowler 2002, New England Journal of MedicineGrade A

    Diabetes Prevention Program: in 3,234 adults with prediabetes, metformin cut new diabetes by 31%.

    Read on PubMed (opens in a new tab)
  • Tang 2025, Diabetes, Obesity and MetabolismGrade C

    20 cohort studies, 3.4 million people with type 2 diabetes: metformin users had 24% lower dementia, with very high heterogeneity.

    Read on PubMed (opens in a new tab)
  • Campbell 2018, Journal of Alzheimer's DiseaseGrade C

    Meta-analysis: lower dementia in diabetic metformin users; evidence does not support use by people without diabetes for dementia prevention.

    Read on PubMed (opens in a new tab)
5 more key studies
  • Luchsinger 2016, Journal of Alzheimer's DiseaseGrade C

    Pilot trial, 80 overweight adults with memory-type MCI: metformin improved one memory test over 12 months; other measures unchanged.

    Read on PubMed (opens in a new tab)
  • Seminer 2025, JAMA Neurology

    Meta-analysis of 26 trials of glucose-lowering drugs and dementia found no metformin trials at all.

    Read on PubMed (opens in a new tab)
  • Kim 2026, Journal of Alzheimer's Disease

    76 adults with diabetes: metformin use went with thicker Alzheimer's-signature cortex and better cognition in non-carriers, not in APOE4 carriers.

    Read on PubMed (opens in a new tab)
  • Zhang 2019, FASEB Journal (mice)

    Animal or lab study

    Animal study: metformin improved memory in aged APOE3 mice but not in APOE4 mice.

    Read on PubMed (opens in a new tab)
  • Chapman 2016, Diabetes & MetabolismGrade B

    Meta-analysis: metformin lowers vitamin B12, leading to deficiency in some patients; B12 monitoring is prudent.

    Read on PubMed (opens in a new tab)

What Kevin and experts say

1 passage with a caution, 4 also discussed

Now showing: Dr. Kevin Tran · 27:16

Open on YouTube (opens in a new tab)

With a caution1 passage

  1. 27:16APOE4: Proof that Lifestyle Beats Genetics - 11-Year Study Data ·

    Metformin may suit carriers with high insulin.

    “using metformin as a precision add-on for people with high insulin or pre-diabetes”

    Dr. Kevin Tran, Founder of The Phoenix Community, Doctor of Pharmacy, APOE4/4 carrier

Also discussed4 passages

  1. 26:43APOE4: Proof that Lifestyle Beats Genetics - 11-Year Study Data ·

    Metformin plus lifestyle is being tested.

    “The first track we combined and the study is ongoing is [metformin]”

    Dr. Miia Kivipelto, Lead of the FINGER lifestyle trial, Karolinska Institutet (conference clips)

  2. 57:33Your p-tau Went Up... Does That Actually Mean Your Brain Getting Worse? ·

    Likely metformin: dementia benefit debated; he sees a modest effect.

    “There's controversy there as to whether that decreases rate of dementia. I would say there's at least a modest effect.”

    Dr. Grant Fraser, Board-certified anti-aging and family medicine physician, APOE4 carrier

  3. 58:23APOE4: Your Brain Is Insulin Resistant (Even If Your Labs Are Normal) ·

    Metformin is a weaker choice for brain glucose.

    “Metformin probably has less evidence as far as you know, improving glucose metabolism in the brain.”

    Dr. Grant Fraser, Board-certified anti-aging and family medicine physician, APOE4 carrier

  4. 20:19Simple Blood Test Detects Alzheimer's 15-20 Years Before Symptoms (P-tau217 + Other New Biomarkers) ·

    Metabolic problems call for metabolic fixes.

    “You'd focus on metabolic interventions like let's say taking [metformin] or even doing intermittent fasting.”

    Dr. Kevin Tran, Founder of The Phoenix Community, Doctor of Pharmacy, APOE4/4 carrier

Last reviewed

Questions about Metformin

What is the effect of Metformin for APOE4 carriers?

Phoenix has measured Metformin against 4 exact outcomes for APOE4 carriers. Member #2351C3's Glucose moved from 114 to 88 mg/dL in 718 days. Member #15000A lowered fasting insulin from 12.6 to 6.5 uIU/mL in 162 days on metformin and tirzepatide, both undated. Member #2351C3's LDL cholesterol moved from 83 to 59 mg/dL in 881 days. Member #2351C3's Triglycerides moved from 101 to 62 mg/dL in 795 days.

Does Metformin change Glucose for APOE4 carriers?

Member #2351C3's Glucose moved from 114 to 88 mg/dL in 718 days. Support: 1 logged members, 1 members with repeats, 1 observations, 2 measurements.

Does Metformin change Insulin for APOE4 carriers?

Member #15000A lowered fasting insulin from 12.6 to 6.5 uIU/mL in 162 days on metformin and tirzepatide, both undated. Support: 1 logged members, 1 members with repeats, 1 observations, 2 measurements.

Does Metformin change LDL cholesterol for APOE4 carriers?

Member #2351C3's LDL cholesterol moved from 83 to 59 mg/dL in 881 days. Support: 1 logged members, 1 members with repeats, 1 observations, 2 measurements.

Does Metformin change Triglycerides for APOE4 carriers?

Member #2351C3's Triglycerides moved from 101 to 62 mg/dL in 795 days. Support: 1 logged members, 1 members with repeats, 1 observations, 2 measurements.

What changed for real APOE4 carriers?

Search by health goal or intervention to see what changed for real members, including results that moved the wrong way.

Want to see how this affects you? Phoenix tracks it beside your labs and how you feel.

Apply to join Phoenix

Metformin · 4 outcomes shown.

Intervention categoryMedications
InterventionMetformin

Metformin

MedicationsOutcomes: 4

Glucose: Decrease 26 mg/dL

Cases: 1

Insulin: Decrease 6.1 uIU/mL

Cases: 1

LDL cholesterol: Decrease 24 mg/dL

Cases: 1

Triglycerides: Decrease 39 mg/dL

Cases: 1

The Beat the Odds Study

The 43-page study: what members tried, how their bloodwork and wearable results changed, and what else changed alongside them.

Download the Beat the Odds Study

Turn evidence into your next test

I built this so nobody has to be the first to try something.

476 members have already tried, measured and logged. Join Phoenix and your next blood draw joins the same Navigator you are reading.

Apply to join Phoenix

Full research index

Find a goal, marker, intervention or question

Choose an outcome, like LDL cholesterol or sleep, or an intervention, like training: both paths open the same measured records.